British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 4 , Pages 263-272 , August 2006

Haemangiomas and vascular malformations of the maxillofacial region—A review

Received 19 January 2005 ,Accepted 29 June 2005.

References 

  1. Waner M, Suen JY. Hemangiomas and vascular malformations of the head and neck. New York: Wiley-Liss; 1999;
  2. Mulliken JB, Young AE. Vascular birthmarks. Hemangiomas and malformations. Philadelphia: Saunders; 1988;
  3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–422
  4. Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, et al. Rapidly involuting congenital hemangioma: clinical and histopathological features. Pediatr Dev Pathol. 2003;6:495–510
  5. Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare vascular anomaly. Plast Reconstr Surg. 2001;107:1647–1654
  6. North PE, Waner M, James CA. Congenital nonprogressive hemangioma: a distinct clinicopathological entity unlike infantile hemangioma. Arch Dermatol. 2001;137:1607–1620
  7. Burrows P, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998;16:455–488
  8. Robertson RL, Robson CD, Barnes PD, Burrows PE. Head and neck vascular anomalies of childhood. Neuroimaging Clin N Am. 1999;9:115–132
  9. Meyer JS, Hoffer FA, Barnes PD, Mulliken JB. Biological classification of soft tissue vascular anomalies: MR correlation. AJR. 1991;157:559–564
  10. Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am. 2002;10:363–388
  11. Platiel HJ, Burrows PE, Kozakewich HPW , Zurakowski D, Mulliken JB. Soft tissue vascular anomalies: utility of US for diagnosis. Radiology. 2002;214:747–754
  12. Jackson IT, Carreno R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993;91:1216–1230
  13. Esterly NB, Margileth AM, Kahn G. Special symposia: the management of disseminated eruptive hemangiomata in infants. Pediatr Dermatol. 1984;1:312–317
  14. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC. The non-random distribution of facial hemangiomas. Arch Dermatol. 2003;139:869–875
  15. Orlow SK, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131:977–980
  16. Takahashi K, Mulliken JB, Kozakewich , Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357–2364
  17. Margileth AM, Museles M. Cutaneous hemangiomas in children: diagnosis and conservative management. JAMA. 1965;194:523–526
  18. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894–900
  19. Dieterich-Miller CA, Safford PL. Psychosocial development of children with hemangiomas: home, school, health care collaboration. Child Health Care. 1992;21:84–89
  20. Kunkel EJ, Zager RP, Hausman CL, Rabinowitz LG. An interdisciplinary group for parents of children with hemangiomas. Psychosomatics. 1994;35:524–532
  21. Enjolras O, Riche MD, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990;85:491–498
  22. Williams EF, Stanislaw P, Dupree M, Mourtzikos K, Mihm M, Shannon L. Hemangiomas in infants and children: an algorithm for intervention. Arch Facial Plast Surg. 2000;2:103–111
  23. Troilius A, Wrangsjo B, Ljunggren B. Potential psychological benefits from early treatment of portwine stain in children. Br J Dermatol. 1998;139:59–65
  24. Miller AC, Pit-Ten Cate IM, Watson HS, Geronemus RG. Stress and family satisfaction in parents of children with facial port-wine stains. Pediatr Dermatol. 1999;16:190–197
  25. Bennett ML, Fleischer AB, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137:1208–1213
  26. Boon LM, Macdonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangiomas. Plast Reconstr Surg. 1999;104:1616–1623
  27. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456–1463
  28. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132:527–530
  29. Hohenleutner S, Badur-Ganter E, Landthaler M, Hohenleutner U. Long term results in the treatment of childhood hemangioma with flash lamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med. 2001;28:273–277
  30. Garden JM, Bakus AD, Paller AS. Treatment of cutaneous hemangiomas by flash lamp-pumped pulsed dye laser. Prospective analysis. J Pediatr. 1992;120:555–560
  31. Waner M, Suen JY. Treatment of hemangiomas of the head and neck. Laryngoscope. 1992;102:1123–1132
  32. Waner M, Suen JY, Dinehart S, Mallory S. Laser photocoagulation of superficial proliferating hemangioms. J Dermatol Surg Oncol. 1994;20:1–4
  33. Barlow RJ, Walker NP, Markey AC. Treatment of proliferative hemangiomas with the 585nm pulsed dye laser. Br J Dermatol. 1996;134:700–704
  34. Landthaler M, Hohenleutner U, El-Raheem TA. Laser treatment of childhood hemangiomas. Br J Dermatol. 1995;133:275–281
  35. Clymer MA, Fortune DS, Reinisch L, Toriumi DM, Werkhaven JA, Ries WR. Interstitial Nd:YAG photocoagulation for vascular malformations and hemangiomas in childhood. Arch Otolaryngol Head Neck Surg. 1998;124:431–436
  36. Achauer BM, Celikoz B, Vanderkam VM. Intralesional bare fibre laser treatment of hemangioma of infancy. Plast Reconstr Surg. 1998;101:1212–1217
  37. Burstein FD, Simms C, Cohen SR, Williams JK, Paschal M. Intralesional laser therapy of extensive hemangiomas in 100 consecutive pediatric patients. Ann Plast Surg. 2000;44:188–194
  38. Sadan N, Wolach B. Treatment of hemangiomas with high dose prednisolone. J Pediatr. 1996;128:141–146
  39. West TB, Alster TS. Comparison of the long pulse dye (590–595nm) and KTP (532nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24:221–226
  40. Cassuto D, Anacona D, Emanuelli G. Treatment of facial telengiectasias with diode-pumped Nd-YAG laser at 532nm. J Cutan Laser Ther. 2000;2:141–146
  41. Zide BM, Glat PM, Stile FL, Longaker MT. Vascular lip enlargement: hemangiomas-tenets of therapy. Plast Reconstr Surg. 1997;100:1664–1673
  42. Waner M. Laser resurfacing and the treatment of involuting hemangiomas. Lasers Surg Med. 1996;40(Suppl. 8):219
  43. Low DW. Management of adult facial vascular anomalies. Facial Plast Surg. 2003;19:113–129
  44. Boyd JB, Mulliken JB, Kaban LB, Upton J, Murray JE. Skeletal changes associated with vascular malformations. Plast Reconstr Surg. 1984;74:789–795
  45. Smoller BR, Rosen S. Port-wine stains: a disease of altered neural modulation of blood vessels. Arch Dermatol. 1986;122:177–179
  46. Rydh M, Malm M, Jernbeck J, Dalsgaard C. Ectatic blood vessels in port-wine stains lack innervation: possible role in pathogenesis. Plast Reconstr Surg. 1991;87:419–422
  47. Waner M. Classification of portwine stains. Facial Plast Surg. 1989;6:162–166
  48. Kaban LB, Mulliken JB. Vascular anomalies of the maxillofacial region. J Oral Maxillofac Surg. 1986;44:203–213
  49. Persky MS, Yoo HJ, Berenstein A. Management of vascular malformations of the mandible and maxilla. Laryngoscope. 2003;113:1885–1892
  50. Kahout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg. 1998;102:643–654
  51. Coffin CM, Dehner LP. Vascular tumors in children and adolescents: A clinicopathological study of 228 tumors in 222 patients. Pathol Annu. 1993;28:97–120
  52. Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. 1995;95:951–960
  53. Ricciardelli EJ, Richardson MA. Cervicofacial cystic hygroma. Patterns of recurrence and management of the difficult case. Arch Otolaryngol Head Neck Surg. 1991;117:546–553
  54. Whimster IW. The pathology of lymphangioma circumscriptum. Br J Dermatol. 1976;94:473–486
  55. Moore MH, David DJ. Craniofacial deformation in cystic hygroma. J Craniofac Surg. 1990;1:97–102
  56. Williams HB. Facial bone changes with vascular tumors in children. Plast Reconstr Surg. 1979;63:309–316
  57. Levine C. Primary disorders of the lymphatic vessels—a unified concept. J Pediatr Surg. 1989;24:233–240
  58. Namba Y, Mae O, Ao M. The treatment of port-wine stains with a dye laser: a study of 644 patients. Scand J Plast Reconstr Surg Hand Surg. 2001;35:197–202
  59. Reyes BA, Geronemus R. Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser. J Am Acad Dermatol. 1990;23:1142–1148
  60. Onizuka K, Tsuneda K, Shibata Y, Ito S, Sekine I. Efficacy of flashlamp-pumped pulsed dye laser therapy of port wine stains: clinical assessment and histopathological characteristics. Br J Plast Surg. 1995;48:271–279
  61. Levine VJ, Geronemus RG. Adverse effects associated with 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients. J Am Acad Dermatol. 1995;32:613–617
  62. Orten SS, Waner M, Flock S, Roberson PK, Kincannon J. Port-wine stains: an assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg. 1996;122:1174–1179
  63. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–527
  64. Chowdhury MM, Harris S, Lanigan SW. Potassium titanyl phosphate laser treatment of resistant port-wine stains. Br J Dermatol. 2001;144:814–817
  65. Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol. 1998;139:173–177
  66. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104:1–11
  67. Landthaler M, Haina D, Waidelich W, Braun-Falco O. Laser therapy of venous lakes (Bean-Walsh) and telangiectasias. Plast Reconstr Surg. 1984;73:78–83
  68. Gongloff RK. Treatment of intra oral hemangiomas with nitrous oxide cryosurgery. Oral Surg Oral Med Oral Pathol. 1983;56:20–24
  69. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341:173–181
  70. Rebeiz E, April MM, Bohigian RK, Shapshay SM. Nd-YAG laser treatment of venous malformations of the head and neck: an update. Otolaryngol Head Neck Surg. 1991;105:655–661
  71. Rosenfeld H, Sherman R. Treatment of cutaneous and deep vascular lesions with the Nd:YAG laser. Laser Surg Med. 1986;6:20–23
  72. Derby LD, Low DW. Laser treatment of facial venous vascular malformations. Ann Plast Surg. 1997;38:371–378
  73. Svendsen P, Wikholm G, Fogdestam I, Naredi S, Eden E. Instillation of alcohol into venous malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg. 1994;28:279–284
  74. De Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg. 1995;30:188–193
  75. Siniluoto TM, Svendsen PA, Wikholm GM, Fogedestam I, Edstrom S. Percutaneous sclerotherapy of venous malformations in the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31:145–150
  76. Azzzolini A, Bertani A, Riberti C. Superselective embolisation and immediate surgical treatment: our present approach to treatment of vascular hemangiomas of the face. Ann Plast Surg. 1982;9:42–60
  77. Enjolras O, Logeart I, Gelbert F, Lemarchand-Venencie F, Reizine D, Guichard JP, et al. Arterivenous malformations: a study of 200 cases. Ann Dermatol Venereol. 2000;127:17–22
  78. Burrows PE, Lasjaunias PL, Ter Brugge KG, Flodmark O. Urgent and emergent embolisation of lesions of the head and neck in children: indications and results. Pediatrics. 1987;80:386–394
  79. Hancock B, St Vil D, Luks F, Dilorenzo M, Blanchard H. Complications of lymphangiomas in children. J Pediatr Surg. 1992;27:220–226
  80. Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg. 1994;29:784–785
  81. Banieghlal B, Davies MR. Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg. 2003;13:103–107
  82. Giguere CM, Bauman NM, Sata Y, Burke DK, Greinwald JH, Pransky S, et al. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol Head Neck Surg. 2002;128:1137–1144

PII: S0266-4356(05)00224-X

doi: 10.1016/j.bjoms.2005.06.032

British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 4 , Pages 263-272 , August 2006

Article Tools

* Image Usage & Resolution